Hashimoto's encephalopathy.

J Assoc Physicians India

Dept. of Medicine, Medical College, 88 College Street, Kolkata-700073.

Published: May 2012

AI Article Synopsis

  • Hashimoto's encephalopathy (HE) is a treatable but recurring neuroendocrine disorder linked to Hashimoto's thyroiditis and often less reported despite its neurological symptoms.
  • A 65-year-old female patient with diabetes presented in a deep coma after experiencing mild fever and vomiting; tests ruled out other causes and indicated high anti-TPO antibodies with otherwise normal thyroid function.
  • After receiving intravenous dexamethasone and later azathioprine, the patient gradually regained consciousness over a month, highlighting the importance of considering HE in comatose patients when other causes have been eliminated.

Article Abstract

Hashimoto's encephalopathy (HE) is a completely treatable but relapsing neuroendocrine disorder associated with Hashimoto's thyroiditis (HT). Though numerous neurological manifestations are often associated with thyroid disorder, this entity is less documented. We are reporting a case of HE in a 65 year old female presenting with sudden onset deep coma following an attack of mild fever and vomiting for two days. Patient was a known diabetic. Hypoglycemic coma, diabetic ketacidosis and hyperosmolar coma were excluded by laboratory investigations. High blood sugar was corrected with insulin. She had hyponatremia and hypokalemia which were corrected with electrolyte replacement. Liver function tests were normal, but serum ammonia was mildly raised. CSF study was normal. Despite correction of her metabolic derangements patient failed to regain her consciousness. CT scan of brain was normal. MRI of brain revealed diffuse brain atrophy. Patient's thyroid function tests were normal but anti-thyroid peroxidase (anti-TPO) antibody was highly raised. EEG showed diffuse slow wave pattern. Intravenous dexamethasone (24 mg/d) was started. Patient regained consciousness slowly over a period of one month. To reduce the toxicity of steroid, oral azathiprine 50 mg/day was added later with tapering of steroid dose. HE must be kept in mind in comatose patients when other metabolic, infective and structural neurological causes have been excluded. Proper and timely treatment can salvage the patient.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hashimoto's encephalopathy
8
function tests
8
tests normal
8
encephalopathy hashimoto's
4
encephalopathy completely
4
completely treatable
4
treatable relapsing
4
relapsing neuroendocrine
4
neuroendocrine disorder
4
disorder associated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!